Camilla Sylvest
Directeur/Membre du Conseil chez ARGENX SE
Fortune : 84 396 $ au 30/04/2024
Postes actifs de Camilla Sylvest
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2003 | - |
| Sales & Marketing | 01/01/2003 | 01/01/2013 | |
| ARGENX SE | Directeur/Membre du Conseil | 08/09/2022 | - |
| Independent Dir/Board Member | 08/09/2022 | - | |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 18/10/2011 | - |
Danish Crown A/S
 Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - | |
| World Diabetes Foundation | Directeur/Membre du Conseil | - | - |
Historique de carrière de Camilla Sylvest
Formation de Camilla Sylvest
| Scandinavian International Management Institute | Masters Business Admin |
| University of Southern Denmark | Graduate Degree |
Statistiques
Internationale
| Danemark | 6 |
| Allemagne | 2 |
| Pays-Bas | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ARGENX SE | Health Technology |
| Entreprise privées | 3 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
| World Diabetes Foundation | Miscellaneous |
- Bourse
- Insiders
- Camilla Sylvest
- Expérience
